PTCT
Ptc Therapeutics margins
- Stocks
- Healthcare
- NASDAQ: PTCT
- Margins
Currently, Ptc Therapeutics shows a gross margin of 93.2%, an operating margin of 12.8%, an EBITDA margin of 15.7%, and a net margin of -9.2%; its net margin is negative at -9.2%. Each available margin deteriorated from the same period last year. Net margin recorded the strongest contraction, dropping by 51.5 percentage points.
PTCT margin history
Ptc Therapeutics's margins averaged 94.18% gross, 0.23% operating, 11% EBITDA, and -13.54% net during the last 3 years. Against the three-year averages, operating, EBITDA, and net margins are above their three-year averages and gross margin is below its three-year average.
PTCT margin expansion
The biggest contraction was in net margin, which fell by 51.5 percentage points. The other available margins also declined.
PTCT Gross margin
Ptc Therapeutics's gross margin averaged 94.18% in the last 3 years. Compared with its three-year average, Ptc Therapeutics's current gross margin is 93.2% and is 1 percentage points below its three-year average. Over the last 3 years, Ptc Therapeutics's gross margin peaked at 97.3% in Dec 2025 and reached a low of 92.2% in Sep 2024.
PTCT Operating margin
Over the last 3 years, the average operating margin for Ptc Therapeutics was 0.23%. The latest operating margin for Ptc Therapeutics is 12.8%, 12.6 percentage points above its three-year average. Ptc Therapeutics's operating margin ranged from a low of -60.5% in Dec 2023 to a high of 50% in Dec 2025.
PTCT EBITDA margin
Ptc Therapeutics recorded an average EBITDA margin of 11% across the last 3 years. Compared with its three-year average, Ptc Therapeutics's current EBITDA margin is 15.7% and is 4.7 percentage points above its three-year average. Ptc Therapeutics's EBITDA margin ranged from a low of -34.2% in Dec 2023 to a high of 51.7% in Dec 2025.
PTCT Net margin
The average net margin for Ptc Therapeutics was -13.54% in the last 3 years. Currently, the current net margin for Ptc Therapeutics is -9.2%, 4.3 percentage points above its three-year average. The net margin for Ptc Therapeutics moved between -66.8% in Dec 2023 and 42.3% in Sep 2025.
PTCT margin group comparison
With a gross margin of 93.2%, PTCT stands higher than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 68.4%, Ptc Therapeutics's gross margin is 36% higher.
PTCT margin peer comparison
Frequently asked questions
What is Ptc Therapeutics's gross margin?
For the period ending Sep 30, 2026, PTCT recorded a gross margin of 93.2%.
What is Ptc Therapeutics's operating margin?
As of Sep 30, 2026, PTCT has an operating margin of 12.8%.
What is Ptc Therapeutics's EBITDA margin?
The current EBITDA margin for PTCT is 15.7% as of Sep 30, 2026.
What is Ptc Therapeutics's net margin?
The current net margin for PTCT is -9.2% as of Sep 30, 2026.
What are the average margins of PTCT?
The three-year average margins for PTCT were 94.2% gross, 0.2% operating, 11.0% EBITDA, and -13.5% net.
What are the highest historical margins of PTCT?
Ptc Therapeutics's highest recorded margins during the past 5 years were 97.3% gross in Dec 2025, 50% operating in Dec 2025, 51.7% EBITDA in Dec 2025, and 42.3% net in Sep 2025.
What are the lowest historical margins of PTCT?
Looking back across 5 years, PTCT reached its lowest margins at 92.2% gross in Sep 2024, -95.8% operating in Sep 2023, -67% EBITDA in Dec 2021, and -97.3% net in Dec 2021.